NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The Cato Corporation ("Cato" or the "Company") (NYSE:CATO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cato and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=124456&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Informa TechTarget ("Informa" or the "Company") (NASDAQ:TTGT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Informa and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of e.l.f. Beauty, Inc. ("e.l.f. Beauty" or the "Company") (NYSE:ELF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether e.l.f. Beauty and certain of its
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MediaAlpha, Inc. ("MediaAlpha" or the "Company") (NYSE:MAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether MediaAlpha and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=124455&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ:FTRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fortrea and certain of its officers and/or
Company Provided Continued Stable Support for Affordable Rental Housing and Other Essential Multifamily Market Sectors Fannie Mae (OTCQB: FNMA) provided more than $55 billion in financing to support the U.S. multifamily market in 2024, the company announced today. Through its network of Delegated Underwriting and Servicing (DUS®) lender partners, Fannie Mae continued to serve the
AMI®, the global leader in Dynamic Firmware for worldwide computing, is excited to announce it is bringing its expertise in industry-leading silicon firmware solutions to the Arm® Total Design ecosystem, aimed at accelerating development of custom silicon on Arm Compute Subsystems (CSS). In addition, AMI announced it is contributing its silicon firmware expertise to Arm's
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ("Johnson & Johnson") (NYSE:JNJ) concerning possible violations of federal securities laws. J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance